These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 19699082

  • 1. Hypoxia in larynx carcinomas assessed by pimonidazole binding and the value of CA-IX and vascularity as surrogate markers of hypoxia.
    Hoogsteen IJ, Lok J, Marres HA, Takes RP, Rijken PF, van der Kogel AJ, Kaanders JH.
    Eur J Cancer; 2009 Nov; 45(16):2906-14. PubMed ID: 19699082
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer.
    Kaanders JH, Wijffels KI, Marres HA, Ljungkvist AS, Pop LA, van den Hoogen FJ, de Wilde PC, Bussink J, Raleigh JA, van der Kogel AJ.
    Cancer Res; 2002 Dec 01; 62(23):7066-74. PubMed ID: 12460928
    [Abstract] [Full Text] [Related]

  • 4. Comparison between pimonidazole binding, oxygen electrode measurements, and expression of endogenous hypoxia markers in cancer of the uterine cervix.
    Jankovic B, Aquino-Parsons C, Raleigh JA, Stanbridge EJ, Durand RE, Banath JP, MacPhail SH, Olive PL.
    Cytometry B Clin Cytom; 2006 Mar 01; 70(2):45-55. PubMed ID: 16456867
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Detecting changes in tumor hypoxia with carbonic anhydrase IX and pimonidazole.
    Shin KH, Diaz-Gonzalez JA, Russell J, Chen Q, Burgman P, Li XF, Ling CC.
    Cancer Biol Ther; 2007 Jan 01; 6(1):70-5. PubMed ID: 17172824
    [Abstract] [Full Text] [Related]

  • 9. The prognostic value of endogenous hypoxia-related markers for head and neck squamous cell carcinomas treated with ARCON.
    Jonathan RA, Wijffels KI, Peeters W, de Wilde PC, Marres HA, Merkx MA, Oosterwijk E, van der Kogel AJ, Kaanders JH.
    Radiother Oncol; 2006 Jun 01; 79(3):288-97. PubMed ID: 16730088
    [Abstract] [Full Text] [Related]

  • 10. HIF-1α and CA-IX as predictors of locoregional control for determining the optimal treatment modality for early-stage laryngeal carcinoma.
    Kwon OJ, Park JJ, Ko GH, Seo JH, Jeong BK, Kang KM, Woo SH, Kim JP, Hwa JS, Carey TE.
    Head Neck; 2015 Apr 01; 37(4):505-10. PubMed ID: 24677746
    [Abstract] [Full Text] [Related]

  • 11. Tumour cell proliferation under hypoxic conditions in human head and neck squamous cell carcinomas.
    Wijffels KI, Marres HA, Peters JP, Rijken PF, van der Kogel AJ, Kaanders JH.
    Oral Oncol; 2008 Apr 01; 44(4):335-44. PubMed ID: 17689286
    [Abstract] [Full Text] [Related]

  • 12. Hypoxia in human colorectal adenocarcinoma: comparison between extrinsic and potential intrinsic hypoxia markers.
    Goethals L, Debucquoy A, Perneel C, Geboes K, Ectors N, De Schutter H, Penninckx F, McBride WH, Begg AC, Haustermans KM.
    Int J Radiat Oncol Biol Phys; 2006 May 01; 65(1):246-54. PubMed ID: 16618579
    [Abstract] [Full Text] [Related]

  • 13. The presence of a fibrotic focus in invasive breast carcinoma correlates with the expression of carbonic anhydrase IX and is a marker of hypoxia and poor prognosis.
    Colpaert CG, Vermeulen PB, Fox SB, Harris AL, Dirix LY, Van Marck EA.
    Breast Cancer Res Treat; 2003 Sep 01; 81(2):137-47. PubMed ID: 14572156
    [Abstract] [Full Text] [Related]

  • 14. Vascular architecture and hypoxic profiles in human head and neck squamous cell carcinomas.
    Wijffels KI, Kaanders JH, Rijken PF, Bussink J, van den Hoogen FJ, Marres HA, de Wilde PC, Raleigh JA, van der Kogel AJ.
    Br J Cancer; 2000 Sep 01; 83(5):674-83. PubMed ID: 10944611
    [Abstract] [Full Text] [Related]

  • 15. GLUT-1 and CAIX as intrinsic markers of hypoxia in carcinoma of the cervix: relationship to pimonidazole binding.
    Airley RE, Loncaster J, Raleigh JA, Harris AL, Davidson SE, Hunter RD, West CM, Stratford IJ.
    Int J Cancer; 2003 Mar 10; 104(1):85-91. PubMed ID: 12532423
    [Abstract] [Full Text] [Related]

  • 16. Immunohistochemical detection of osteopontin in advanced head-and-neck cancer: prognostic role and correlation with oxygen electrode measurements, hypoxia-inducible-factor-1alpha-related markers, and hemoglobin levels.
    Bache M, Reddemann R, Said HM, Holzhausen HJ, Taubert H, Becker A, Kuhnt T, Hänsgen G, Dunst J, Vordermark D.
    Int J Radiat Oncol Biol Phys; 2006 Dec 01; 66(5):1481-7. PubMed ID: 17056190
    [Abstract] [Full Text] [Related]

  • 17. Metabolic markers in relation to hypoxia; staining patterns and colocalization of pimonidazole, HIF-1α, CAIX, LDH-5, GLUT-1, MCT1 and MCT4.
    Rademakers SE, Lok J, van der Kogel AJ, Bussink J, Kaanders JH.
    BMC Cancer; 2011 May 12; 11():167. PubMed ID: 21569415
    [Abstract] [Full Text] [Related]

  • 18. Prognostic value of carbonic anhydrase IX and Ki-67 expression in squamous cell carcinoma of the tongue.
    Kim SJ, Shin HJ, Jung KY, Baek SK, Shin BK, Choi J, Kim BS, Shin SW, Kim YH, Kim JS, Oosterwijk E.
    Jpn J Clin Oncol; 2007 Nov 12; 37(11):812-9. PubMed ID: 18057013
    [Abstract] [Full Text] [Related]

  • 19. Comparison of different methods of CAIX quantification in relation to hypoxia in three human head and neck tumor lines.
    Troost EG, Bussink J, Kaanders JH, van Eerd J, Peters JP, Rijken PF, Boerman OC, van der Kogel AJ.
    Radiother Oncol; 2005 Aug 12; 76(2):194-9. PubMed ID: 16024110
    [Abstract] [Full Text] [Related]

  • 20. Carbonic anhydrase IX expression in prostate cancer.
    Smyth LG, O'Hurley G, O'Grady A, Fitzpatrick JM, Kay E, Watson RW.
    Prostate Cancer Prostatic Dis; 2010 Jun 12; 13(2):178-81. PubMed ID: 20038959
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.